Crossmark

Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis

Crossref DOI link: https://doi.org/10.1007/s11095-016-1974-5

Published Online: 2016-06-28

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Young, E. F.

Perkowski, E.

Malik, S.

Hayden, J. D.

Durham, P. G.

Zhong, L.

Welch, J. T.

Braunstein, Miriam S.

Hickey, Anthony J.
Funding

Funding for this research was provided by:

AIDS Clinical Trials Group (UM1 AI068636)

AIDS Clinical Trials Group (UM1 AI068636)
License Information

License valid from 2016-06-28